Recombinant Domain V of beta (2)-Glycoprotein I Inhibits OxLDL-induced TF Expression in Macrophages

被引:0
|
作者
Chi, Yan [1 ]
Li, Mingying [1 ]
Yu, Tiantian [1 ]
Qin, Jianzhong [1 ]
Li, Jingda [1 ]
Chen, Yuhua [1 ]
Liu, Qingping [1 ]
机构
[1] Dalian Univ, Coll Life Sci & Technol, Key Lab Carbohydrate & Lipid Metab Res, Dalian, Peoples R China
基金
中国国家自然科学基金;
关键词
Tissue factor; Oxidised low density lipoprotein; Lectin-like oxidised LDL receptor; Beta (2)-Glycoprotein; TISSUE FACTOR; OXIDIZED LDL; BETA(2)-GLYCOPROTEIN I; COMPLEXES; 7-KETOCHOLESTERYL-9-CARBOXYNONANOATE; BETA-2-GLYCOPROTEIN-I; MICROPARTICLES;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To investigate if lectin-like oxidised low density lipoprotein receptor is implicated in oxidised low density lipoprotein induced up-regulation of tissue factor and whether recombinant domain V of beta (2)-Glycoprotein I expressed in Pichia pastoris inhibits the binding of oxidised and lectin-like low density lipoprotein. Methods: The expression of tissue factor and lectin-like oxidised low density lipoprotein receptor was detected using Western blot methods. Small interference ribonucleic acid of lectin-like oxidised low density lipoprotein receptor was used to block lectin-like oxidised low density lipoprotein receptor expression. Flow cytometry was used to test the effect of beta (2)-Glycoprotein I expressed in Pichia pastoris on the binding of oxidised low density lipoprotein with lectin-like oxidised low density lipoprotein receptor by using the lectin-like oxidised low density lipoprotein receptor-expressing 293T cells. Results: Oxidised low density lipoprotein at 5-10 mu g/mL increased tissue factor and lectin-like oxidised low density lipoprotein receptor expression, whereas 20-50 mu g/mL oxidised low density lipoprotein attenuated tissue factor expression. Inhibiting lectin-like oxidised low density lipoprotein receptor expression by small interference ribonucleic acid of lectin-like oxidised low density lipoprotein receptor impaired oxidised low density lipoprotein-induced tissue factor over expression in macrophages. Pretreatment with beta (2)-Glycoprotein I expressed in Pichia pastoris led to a strong inhibition of tissue factor and lectin-like oxidised low density lipoprotein receptor expression in a dose-dependent manner in macrophages. Flow cytometry analysis showed that beta (2)-Glycoprotein I expressed in Pichia pastoris attenuated the interaction of oxidised low density lipoprotein with lectin-like oxidised low density lipoprotein receptor in lectin-like oxidised low density lipoprotein receptor-expressing 293T cells. Conclusions: Lectin-like oxidised low density lipoprotein receptor was implicated in the expression of tissue factor induced by oxidised low density lipoprotein, and beta (2)-Glycoprotein I expressed in Pichia pastoris inhibited oxidised low density lipoprotein-induced tissue factor and lectin-like oxidised low density lipoprotein receptor expression, at least in part, via inhibition of the interaction between oxidised low density lipoprotein and lectin-like oxidised low density lipoprotein receptor.
引用
收藏
页码:1644 / 1649
页数:6
相关论文
共 50 条
  • [31] Autoantibodies Directed Against Domain I of Beta2-Glycoprotein I
    de Laat, Bas
    de Groot, Philip G.
    CURRENT RHEUMATOLOGY REPORTS, 2011, 13 (01) : 70 - 76
  • [32] Autoantibodies Directed Against Domain I of Beta2-Glycoprotein I
    Bas de Laat
    Philip G. de Groot
    Current Rheumatology Reports, 2011, 13 : 70 - 76
  • [33] Pathogenic anti-beta2-glycoprotein I antibodies recognise domain I of beta2-glycoprotein I only after an anionic surface-induced conformational change
    De Laat, B
    Derksen, RHWM
    Van Lummel, M
    Pennings, MT
    De Groot, PG
    BRITISH JOURNAL OF HAEMATOLOGY, 2006, 133 : 5 - 6
  • [34] Development of a high yield expression and purification system for Domain I of Beta-2-glycoprotein I for the treatment of APS
    Thomas McDonnell
    Charis Pericleous
    Emmanuelle Laurine
    Rita Tommasi
    Acely Garza-Garcia
    Ian Giles
    Yiannis Ioannou
    Anisur Rahman
    BMC Biotechnology, 15
  • [35] Development of a high yield expression and purification system for Domain I of Beta-2-glycoprotein I for the treatment of APS
    McDonnell, Thomas
    Pericleous, Charis
    Laurine, Emmanuelle
    Tommasi, Rita
    Garza-Garcia, Acely
    Giles, Ian
    Ioannou, Yiannis
    Rahman, Anisur
    BMC BIOTECHNOLOGY, 2015, 15
  • [36] A novel, efficient, expression system of domain I of human beta2 glycoprotein I in E-coli
    Ioannou, Y
    Giles, I
    Lambrianides, N
    Latchman, DS
    Isenberg, DA
    Rahman, A
    RHEUMATOLOGY, 2005, 44 : I141 - I142
  • [37] Antiphospholipid antibodies can reduce the in vitro cleavage of domain V of beta2-glycoprotein I by plasmin
    Nash, MJ
    Mackie, IJ
    Cohen, H
    Machin, SJ
    THROMBOSIS RESEARCH, 2004, 114 (5-6) : 616 - 616
  • [38] Beta2-glycoprotein I inhibits insulin and insulin-like growth factor induced angiogenesis through its amino terminal domain
    Yu, P.
    Yu, D.
    Krilis, S.
    Qi, J.
    DIABETOLOGIA, 2009, 52 : S435 - S435
  • [39] Beta2-glycoprotein I selectively inhibits the procoagulant functions of thrombin
    De Filippis, V
    Acquasaliente, L.
    Pozzi, N.
    Frasson, R.
    De Cristofaro, R.
    Arcovito, A.
    Banzato, A.
    Pengo, V
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 142 - 143
  • [40] Suppression of oxLDL-Induced MMP-9 and EMMPRIN Expression by Berberine via Inhibition of NF-?B Activation in Human THP-1 Macrophages
    Huang, Zhouqing
    Meng, Shu
    Wang, Liansheng
    Wang, Yue
    Chen, Ting
    Wang, Changqian
    ANATOMICAL RECORD-ADVANCES IN INTEGRATIVE ANATOMY AND EVOLUTIONARY BIOLOGY, 2012, 295 (01): : 78 - 86